MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
63 hedge funds and large institutions have $408M invested in Mirati Therapeutics, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 27 funds opening new positions, 20 increasing their positions, 12 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
67% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 12
29% more funds holding
Funds holding: 49 → 63 (+14)
Holders
63
Holding in Top 10
6
Calls
$2.3M
Puts
$366K
Top Buyers
| 1 | +$17.1M | |
| 2 | +$12.5M | |
| 3 | +$12.5M | |
| 4 |
GTC
Ghost Tree Capital
New York
|
+$10.9M |
| 5 |
Jennison Associates
New York
|
+$8.9M |
Top Sellers
| 1 | -$5.21M | |
| 2 | -$2.75M | |
| 3 | -$2.37M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$2.27M |
| 5 |
D.E. Shaw & Co
New York
|
-$1.8M |